2. Signaling Pathways
  3. MAPK/ERK Pathway
  4. MAPKAPK2 (MK2)
  5. MAPKAPK2 (MK2) Activator

MAPKAPK2 (MK2) Activator

MAPKAPK2 (MK2) Activators (2):

Cat. No. Product Name Effect Purity
  • HY-157793
    SMU-L11
    		Activator 99.64%
    SMU-L11 is a specific TLR7 agonist (EC50=0.024 μM), which recruits MyD88 adapter protein and activates downstream NF-κB and MAPK signaling pathways. In murine models, SMU-L11 significantly enhances immune cell activation and promotes the proliferation of CD4+ T and CD8+ T cells, thereby directly killing tumor cells and inhibiting tumor growth. SMU-L11 can be used for cancer research, and also has the potential for studying immune system diseases.
  • HY-W726640
    Peraquinsin
    		Activator
    Peraquinsin is a MK2 activator. Peraquinsin can be used for the research of vascular disorder or endothelial barrier disorder. Peraquinsin also is an antihypertensive agent.